Product logins

Find logins to all Clarivate products below.


Peripheral Vascular Devices | Market Insights | Japan | 2023

Growing adoption of premium-priced DES and DCBs will be fueled by the continued emergence of data supporting the safety of paclitaxel-coated devices, resulting in modest growth in the Japanese PV device market. The impact of the COVID-19 pandemic in the short term, as well as ASP declines caused by MHLW biennial reimbursement cuts over the forecast period, will limit market revenues.

This Medtech 360 Report provides comprehensive data and analysis on the state of the market for PV devices in Japan from 2019 through 2031.

Related Medtech Insights Reports

Report
Diagnostic Imaging Systems – Market Insights – Japan
Japan’s diagnostic imaging system market will experience slow growth through 2034, driven by continuous technological advancement and rising hospital demand for efficient, patient-centric imaging…
Report
Laparoscopic Devices – Market Insights – Japan
The Japanese laparoscopic device market will expand modestly through 2034, driven by rising demand for MIS procedures among the country’s rapidly aging population. Additionally, the adoption of…
Report
Urological Devices – Market Insights – Japan
The Japanese urological device market will continue to expand through 2034, driven by the rising prevalence of risk factors for urological disorders, such as the growing burden of metabolic…
Report
Peripheral Vascular Devices – Market Insights – Europe
The European PV device market will be mainly driven by the increasing availability of premium-priced products and emerging products which, supported by clinical data, will increase the penetration…
Report
Peripheral Vascular Devices – Market Insights – United States
The US PV device market will be primarily driven by product innovation, novel technologies, and adoption of premium solutions. However, barriers such as the push for cost-effective PV interventions…